An experimental strategy to facilitate correction of single-base mutations of episomal targets in mammalian cells has been developed. The method utilizes a chimeric oligonucleotide composed of a contiguous stretch of RNA and DNA residues in a duplex conformation with double hairpin caps on the ends. The RNA/DNA sequence is designed to align with the sequence of the mutant locus and to contain the desired nucleotide change. Activity of the chimeric molecule in targeted correction was tested in a model system in which the aim was to correct a point mutation in the gene encoding the human liver/bone/kidney alkaline phosphatase. When the chimeric molecule was introduced into cells containing the mutant gene on an extrachromosomal plasmid, correction of the point mutation was accomplished with a frequency approaching 30%. These results extend the usefulness of the oligonucleotide-based gene targeting approaches by increasing specific targeting frequency. This strategy should enable the design of antiviral agents.
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Targeted correction of disease-related mutations or sitedirected inactivation of viral genes by homologous recombination would be a effective strategy for gene therapy. Unfortunately, homologous recombination in mammalian cells between a target gene and an exogenous DNA vector takes place at relatively low frequencies and is complicated by interference from an illegitimate recombination pathway that does not depend on sequence homology (1) (2) (3) (4) (5) . An alternative approach involves targeted mutagenesis facilitated by triple-helixforming oligonucleotides coupled to cross-linking agents (6, 7) . Such oligonucleotides have been used previously to change DNA sequences thereby altering gene expression but these approaches have been limited by the sequence restriction of the target that must consist of homopurine or homopyrimidine stretches (8, 9) . Moreover, the generation of a specific type of mutation or correction has been difficult to achieve (6, 7) .
We have developed an experimental strategy to enable correction of single-base mutations of episomal sequences by using a chimeric oligonucleotide of unique design. This strategy evolved from in vitro studies on homologous recombination conducted with the RecA and Rec2 proteins (10) (11) (12) . Analysis of the homologous pairing reaction promoted by the Rec2 protein of Ustilago maydis revealed that RNADNA hybrids were more active in homologous pairing reactions than corresponding DNA duplexes (10) . Since pairing would appear to be the rate-limiting step during the gene targeting process (13) , the overall frequency of recombination should be elevated if the number of pairing events is elevated. It was also discovered that joint molecule formation proceeded efficiently even when the ends of the hybrid were capped with double hairpin structures. These observations led us to a strategy for gene targeting in which vector design would exploit the natural recombinogenicity of RNA-DNA hybrids and would feature double-hairpin capped ends avoiding destabilization or de- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 2071 struction by cellular helicases or exonucleases. A chimeric oligonucleotide can be designed so that it aligns in perfect register with a specified genomic target or in imperfect register such that a single base pair is different between the oligonucleotide and a specified targeted nucleotide. In the latter case, structural distortion created by the mismatched base pair should be recognized by the endogenous repair systems (14, 15) and a change in sequence on either chimeric oligonucleotide or the target sequence would ensue. An additional feature in the design of chimeric oligonucleotides was modification of the RNA residues by 2'-O-methylation of the ribose sugar (16) to render the oligonucleotide resistant to the RNase H activity present in mammalian cells.
To test the feasibility of chimeric oligonucleotide-based targeting in mammalian cells, we chose an episomal target utilizing human liver/bone/kidney alkaline phosphatase cDNA, whose gene product is important in skeletal mineralization. Mutations in the structural gene give rise to hypophosphatasia, a metabolic bone disease with variable clinical severity ranging from still birth with almost no mineralized bone to pathological fractures in adults (17) . A wellcharacterized mutant form has a missense mutation (G -> A) at position 711 of the cDNA that results in the loss of enzymatic activity (18) . This particular gene was chosen for study since direct biochemical and histochemical assays are available to monitor its activity. With the use of an appropriate chromogenic substrate dye, enzymatic activity can be detected by deposition of pigment on the cells since the enzyme localizes to the cell surface (19) . Chinese hamster ovary (CHO) cells were chosen as hosts since there is little detectable endogenous alkaline phosphatase expressed (19, 20 (20 ,ul) was incubated with 50 ,ul of ELISA substrate and 50 ,A of ELISA amplifier (BRL), the reaction was stopped by addition of 50 ,ul of 0.3 M H2SO4 after 5 min of incubation with amplifier. The extent of reaction was carried out within the linear range of the detection method. The absorbance was read by an ELISA plate reader (BRL) at a wavelength of 490 nm.
Hirt DNA Isolation, Colony Hybridization, and Direct DNA Sequencing of PCR Fragments. The cells were harvested for vector DNA isolation by a modified alkaline lysis procedure (6), 24 h after transfection with the chimeric oligonucleotide. Hirt DNA was transformed into Escherichia coli DH5a cells (BRL). Colonies from Hirt DNA were screened for specific hybridization for each probe designed to distinguish the point mutation. Colonies were grown on ampicillin plates, lifted onto nitrocellulose filter paper in duplicates, and processed for colony hybridization. The blots were hybridized to 32P-end- (19) . When cells with the mutant gene were transfected with the chimeric oligonucleotide Chl, red cells appeared at a high frequency (Fig. 2A) . On the average, Chl promoted the conversion of approximately one in three transfected CHO cells from mutant to wild-type phenotype at 11 nM. In contrast, neither Ch2 nor Dhl increased enzymatic activity (Fig. 2 B and D) . The sequence of Ch2 is similar to that of the Chl, except for the central adenosine substitution producing the identical sequence found in the plasmid p711. Thus, it would not form a mismatch at position 711. The frequency of conversion using Dhl, the DNA oligonucleotide with the sequence identical to Chl, was also extremely low (Fig. 2D) (Fig. 2C) . It is not clear why there should be such a difference between the effectiveness of Chl vs. Ch3, but the transcribed strand may encounter a preferential treatment during the course of homologous pairing or DNA repair process. Transfection frequency measured by the expression of the wild-type plasmid pHAP was estimated to be 30% (Fig. 2E) .
The enzymatic activity was also measured by a spectrophotometric method. A dose-dependent increase of alkaline phosphatase activity was observed up to 17 nM of Chi (Fig. 3) . The enzymatic activity of cells treated with Chl at 17 nM was remarkably high, approaching 60% of that observed from cells transfected with the wild-type plasmid, pHAP. The increase was sequence-specific since the same amount of Chl did not affect the enzymatic activity of cells transfected with pHAP (Fig. 3) (21) . To rule out the possibility that the sequence conversion is mediated by E. coli, direct DNA sequencing of a PCR-amplified fragment of Hirt DNA was carried out. Two primers flanking position 711 were utilized to generate a 192-bp fragment through the action of Vent polymerase. The results indicated that position 711 was a mixture of adenosine (70%) and guanosine (30%) when the Hirt DNA sample was made from the cells transfected with the combination of p711 and Chl (Fig. 4C) . In contrast, no mixed sequence was observed at position 711 when Hirt DNA was made from oligonucleotide Dhl (Fig. 4D) . These results established clearly that sequence correction by the chimeric oligonucleotide occurred in mammalian cells.
Stability of Chimeric Oligonucleotides. The stability of the chimeric oligonucleotide was measured intracellularly and in growth medium containing 10% FBS. Ten nanograms of radiolabeled oligonucleotide, Chl, was added to the same transfection experiment in which histochemical staining and Hirt DNA analyses was conducted. The chimeric oligonucleotides are extremely stable. No detectable degradation was observed when chimeric oligonucleotide was incubated in growth medium containing 10% FBS, after a 24-h incubation (Fig. 5, lane 3) . Moreover, oligonucleotide isolated from cells did not exhibit any degradation during the same incubation time (Fig. 5, lane 2) . Only monomers of the chimeric oligonucleotide were detected when isolated from cells 24 h after incubation. Thus, under the experimental conditions employed here, no end-to-end ligation of chimeric oligonucleotides was observed.
DISCUSSION
These results demonstrate that it is possible to correct a mutant base in a gene by using an oligonucleotide-based strategy with relatively high frequency in a sequence-specific manner. A major modification of the oligonucleotide, incorporation of RNA residues complementary through the central region of Genetics: Yoon et al. It is probable that the gene correction event is mediated by a specific mismatch repair system because Chl and Ch3 were the only effective chimeric molecules in enabling the changes. Both Chl and Ch3 are designed to form the mismatched base pair with the target gene, whereas Ch2 forms a perfect complementary match. Highly efficient repair activity has been observed in nuclear extracts prepared from several mammalian cell lines (22) (23) (24) . Such processes are often strandspecific and bidirectional relative to a nick that is located 5' or 3' of the mismatch (22, 24) . It is possible that RNA-DNA chimeric oligonucleotides may not only enhance the pairing activity but also facilitate the mismatch repair activity to the targeted strand preferentially. The higher rate of correction exhibited by Chl over Ch3 suggests a correlation between DNA repair and transcription, identifying an important strategy for designing effective chimeric oligonucleotides. Similar correlations of transcription and homologous recombination (25, 26) and DNA repair (27, 28) have been established in other systems.
Extrachromosomal homologous recombination has been reported to be more frequent than chromosomal recombination, albeit lower than what we observed in this study (29) (30) (31) (32) (33) . Relatively high frequency approaching 15% was observed when an episomal DNA and a sequence-specific endonuclease were injected into the Xenopus laevis oocyte nucleus (31 (29) . Thus, a cleavage of episomal DNA was required for efficient recombination to occur in both systems, suggesting a nonconservative single-strand annealing mechanism for extrachromosomal homologous recombination (29) (30) (31) (32) (33) . In our experiments, a high frequency of correction was observed when uncleaved extrachromosomal DNA was introduced to mammalian cells followed by 11 nM chimeric oligonucleotides (molar ratio of the oligonucleotide to plasmid = 7). Expression of one corrected plasmid per cell may result in conversion of red cells as seen in histochemical staining (Fig. 2) . However, DNA sequence analysis by selective hybridization suggests that the frequency of episomal targeted mutagenesis approaches 30% (Table 1) . Moreover, a mixture of adenosine (70%) and guanosine (30%) was observed at position 711 by direct sequencing of the PCR-amplified fragment from the Hirt DNA (Fig. 4C) . This result indicates a correction efficiency of 30% among the total population of episomal DNA with no prior biased selection, consistent with the selective hybridization results. Thus, chimeric oligonucleotides appear to facilitate cellular recombination and repair processes of episomal DNA at a frequency higher than previous studies (29-33). In mammalian cells, homologous targeting occurs against a background of nonhomologous events that are more common. Ingenious procedures have been devised to select or screen for the rare successful targeting products, but low absolute frequency of specificity remains a serious limitation (1) (2) (3) (4) (5) . In this work, a high frequency of the targeted event was detected without selection. We considered the possibility that the chimeric oligonucleotide causes nonhomologous recombination events leading to spurious mutations or random integration. We have found no evidence of either type since DNA sequencing of several hundred bases surrounding the target base revealed no alteration in sequence. The chimeric oligonucleotide was stable and remained as a monomer inside the cells, indicating that these molecules were not ligated into concatamers (Fig. 5, lane 2) . This observation also argues against the participation of chimeric oligonucleotide in nonhomologous recombination, in which end-to-end ligation of the double-stranded DNA is often observed prior to integration (see ref. 5 and references therein). Moreover, the kinetics of conversion by chimeric oligonucleotides appears to be fast (<24 h), while most integration events of the double-stranded DNA occur over much longer time periods (1) (2) (3) (4) (5) . To address random integration of Chl, a Southern blot analysis was carried out. The chimeric oligonucleotide hybridized to a single Sau3A fragment containing position 711 of Hirt DNA and did not hybridize at all to the CHO genomic DNA (data not shown). Thus, within our detection limit, we conclude that targeted conversion by this oligonucleotide is highly sequencespecific and more frequent than random nonhomologous recombination events.
This study outlines a way to expand the repertoire of target sequences and to improve the specificity of the targeting event. Viral genes are potential targets for chimeric oligonucleotides as strategically placed mutations can be introduced into the episomal genome to inactivate key viral proteins. Recently, we have achieved a high frequency of genomic targeting by the use of the chimeric oligonucleotide without evidence of random integration or mutation. Such observations should extend the applicability of this therapeutic strategy to human genetic diseases.
